Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

SYRESYRE
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in SPYRE THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 1.8M shares of SYRE (SPYRE THERAPEUTICS INC), worth $157.8M as of 2026-Q2. The position was increased (+44.8% shares). SYRE represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$157.8M

Current Shares

1.8M

Total Value Change

+$157.7M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+44.8%
$157.8M0.0%$88.78
41
2026-Q1
Increased
1.2M
+192.6%
$61.9M0.0%$40.07
48
2025-Q4
Increased
419,727
+21.7%
$13.8M0.0%$31.88
34
2025-Q3
Decreased
344,803
-13.0%
$5.8M0.0%$16.36
0
2025-Q2
Decreased
396,351
-7.2%
$5.9M0.0%$15.22
0
2025-Q1
Increased
427,075
+5879.8%
$6.9M0.0%$17.94
44
2024-Q4
New
7,142
-
$166,2650.0%$22.54
34

Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used